Lumet vs falcigo vs doxy for puo

Reading File

Finding Sources

Reading File

Finding Sources

I now have comprehensive data to give a thorough comparison. Here is the full answer:

Lumet vs Falcigo vs Doxycycline for PUO (Pyrexia of Unknown Origin) - Likely Malaria

In India, when a patient presents with PUO in a malaria-endemic area, empirical antimalarial therapy is often started while awaiting or alongside diagnostic workup. Here is a head-to-head breakdown of the three commonly used agents:

1. Lumet (Artemether 20 mg + Lumefantrine 120 mg) - ACT tablet

Brand name: Lumet, Coartem, Riamet

Class: Artemisinin-based combination therapy (ACT)

Mechanism:

Artemether generates free radicals via cleavage of its endoperoxide bridge by heme iron in the parasite food vacuole - this rapidly kills ring-stage parasites
Lumefantrine (similar to mefloquine/halofantrine) acts as a long-acting partner drug to kill residual parasites and prevent recrudescence

Indication: First-line for uncomplicated P. falciparum malaria (chloroquine-resistant or unknown resistance areas). Also effective for P. vivax.

Adult Dosing:

Each tablet: Artemether 20 mg + Lumefantrine 120 mg
4 tablets per dose (total 6 doses over 3 days):
- Day 1: Dose at 0 h and 8 h
- Day 2 and 3: One dose twice daily (morning and evening)
Must be taken with food or whole milk - lumefantrine absorption is drastically reduced in fasted state

Pediatric Dosing (weight-based):

Weight	Tablets/dose
5-15 kg	1 tablet
15-25 kg	2 tablets
25-<35 kg	3 tablets
>35 kg	4 tablets

Adverse Effects: Headache, dizziness, anorexia, nausea, arthralgia/myalgia, prolonged QT (mild)

Contraindications: First trimester of pregnancy (avoid ACTs), children <5 kg

Key Advantage: Fastest parasite clearance among oral regimens; highly effective even in multidrug-resistant malaria

2. Falcigo (Artesunate) - IV/Oral Artesunate

Brand name: Falcigo (common Indian brand); also Falcigo Plus (artesunate + sulfadoxine-pyrimethamine)

Class: Artemisinin derivative (artesunate)

Forms:

IV/IM artesunate: For severe/complicated malaria
Oral artesunate: Used in ACT combinations (e.g., ACT-SP = artesunate + sulfadoxine-pyrimethamine, the NVBDCP standard in India)

Mechanism: Same endoperoxide-mediated free radical generation. Artesunate is water-soluble and can be given parenterally - key advantage over artemether for severe cases.

Indication:

IV Falcigo/artesunate = drug of choice for severe malaria (superior to IV quinine in randomized trials)
Oral artesunate-SP (ACT-SP) = NVBDCP first-line for uncomplicated falciparum malaria in most Indian states

IV Dosing (Severe malaria):

2.4 mg/kg IV at 0 h, 12 h, 24 h - then reassess
After parenteral, transition to oral artemether-lumefantrine (Lumet) or doxycycline-based regimen to complete treatment

Oral ACT-SP Dosing (India NVBDCP protocol):

Artesunate 4 mg/kg/day for 3 days + Sulfadoxine-Pyrimethamine Day 1 + Primaquine 0.75 mg/kg on Day 2

Adverse Effects: Thrombocytopenia, hemolytic anemia (especially post-treatment), elevated liver enzymes, hyperbilirubinemia

Key Advantage: Only drug proven superior to quinine for severe malaria; essential for complicated presentations

3. Doxycycline - Tetracycline Antibiotic

Class: Tetracycline antibiotic

Mechanism: Inhibits bacterial/protozoal protein synthesis (30S ribosomal subunit); has slow antimalarial activity against blood-stage parasites

Role in Malaria:

Never used as monotherapy for malaria - acts too slowly
Used as partner drug alongside quinine for uncomplicated falciparum malaria (quinine 7 days + doxycycline 7 days) in chloroquine-resistant areas
Also used after IV artesunate as oral follow-on therapy for severe malaria
Serves as malaria prophylaxis (100 mg daily, starting 1-2 days before travel, continued 4 weeks after)

Role in PUO beyond malaria:

Empirical treatment of rickettsial fevers (RMSF, scrub typhus, tick typhus) - doxycycline is the drug of choice
Covers ehrlichiosis, Q fever, leptospirosis (partially)
In India, where scrub typhus is a common cause of PUO (especially in rural areas), doxycycline has high value

Adult Dosing:

100 mg twice daily for 7 days (malaria, with quinine)
100 mg twice daily for 7-14 days (rickettsial fever, scrub typhus)
100 mg daily (prophylaxis)

Adverse Effects: Photosensitivity, GI upset, esophageal ulceration (take with full glass of water, upright), dental discoloration in children

Contraindications: Pregnancy, children <8 years

Comparison Table

Feature	Lumet (AL)	Falcigo (Artesunate)	Doxycycline
Class	ACT (oral)	Artemisinin (IV/oral)	Tetracycline
Primary Use	Uncomplicated malaria	Severe malaria (IV)	Partner drug / rickettsial cover
Monotherapy?	No (fixed combo)	No (needs partner)	No (too slow)
Speed of action	Fast	Fastest	Slow
Route	Oral only	IV/IM/oral	Oral
Pregnancy	Avoid 1st trimester	Avoid 1st trimester	Contraindicated
Children	Yes (>5 kg)	Yes	Avoid <8 yrs
Coverage beyond malaria	None	None	Scrub typhus, rickettsia, ehrlichiosis
NVBDCP first-line?	Yes (some states)	Yes (ACT-SP protocol)	No (adjunct)

Practical Decision Framework for PUO in India

Step 1 - Check for danger signs:

If severe malaria features (altered consciousness, heavy parasitemia, renal failure, jaundice, ARDS) - start IV Falcigo (artesunate) immediately. Transition to oral Lumet (AL) after stabilization.

Step 2 - Uncomplicated malaria / smear positive falciparum:

Use Lumet (AL) or ACT-SP (oral artesunate + SP) per NVBDCP protocol for your state
Take Lumet with food; ensure full 3-day course

Step 3 - Smear negative but strong clinical suspicion of malaria:

Empirical AL (Lumet) is reasonable while repeating smears at 12-24 h intervals

Step 4 - Consider doxycycline if:

Scrub typhus or rickettsial fever is suspected (eschar, rash, tick exposure, lymphadenopathy)
As adjunct to quinine in documented falciparum malaria
Post-artesunate completion therapy

Step 5 - Mixed/unclear PUO:

In many Indian endemic zones, empirical Lumet + Doxycycline covers both malaria and scrub typhus simultaneously, which is a common real-world practice for febrile illness with unknown source

Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics (ACT Partner Drugs, Dosing Tables); Lippincott Pharmacology (Artemisinin section); Park's Textbook of Preventive & Social Medicine (NVBDCP falciparum protocol); Harrison's Principles of Internal Medicine 22E (rickettsial empirical doxycycline)

This is a shared conversation. Sign in to Orris to start your own chat.